| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.17 | 0.05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.05 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.06 |